Introduction
Transient neonatal pustular melanosis (TNPM) is a harmless, self-limiting dermatological disorder affecting neonates. Despite being very rare, it is crucial to identify this disorder because it might be confused with pustular dermatosis or more dangerous newborn infections.1,2 The characteristic skin symptoms of TNPM are unique, change over time, and don't need special care. Paediatricians, neonatologists, and dermatologists must be thoroughly aware of the clinical characteristics, lesion evolution, and presentation to reassure parents appropriately and prevent unnecessary procedures.3
Overview
Full-term and occasionally pre-term newborns can develop transient neonatal pustular melanosis, which usually manifests at birth. Although it can occur in infants of different ethnic backgrounds, it is more common among African-American infants. Pustules that burst, revealing hyperpigmented macules and a collarette of scale, are the defining feature of TNPM.2,4
Notwithstanding its striking look, TNPM is entirely benign and goes away without leaving any scars or affecting the system. TNPM lesions are sterile and do not cause systemic signs like fever or irritability, in contrast to infectious pustular eruptions.5
Causes
The precise cause of TNPM is yet unknown. Nonetheless, numerous theories have been put forth:
Immature pilosebaceous unit response: Transient dermatoses like TNPM may be exacerbated by the immature pilosebaceous unit, which is still adjusting to the extrauterine environment.6,7
Benign inflammatory reaction: TNPM could be a sterile, benign inflammatory reaction.Ethnic predisposition: African-American infants are more likely to have the disorder, which may indicate a genetic or pigment-related component.
Hormonal factors: Changes in hormones during birth may affect the activity of sebaceous glands and cause pustular eruptions.
TNPM has been repeatedly linked to no infectious agent, genetic mutation, or immunologic abnormality, confirming its benign nature.4
Clinical signs and characteristics
TNPM has a distinct clinical presentation that progresses through three major phases:
Pustular stage (Present at birth)
- Superficial, 1–5 mm pustules without surrounding erythema
- Located commonly on the chin, neck, back, chest, limbs, and buttocks
- The palms and soles may also be involved—an unusual finding not typical of other neonatal pustular eruptions3 5
Stage of ruptured pustule
- A transparent or hazy fluid, never purulent, is released when the pustules spontaneously burst. If lesions rupture early, this stage could be missed because it is temporary2,6
Stage of pigmented macule
- Hyperpigmented macules are left behind after lesions rupture
- Usually spherical, flat, and brownish, these macules have a collarette of scales (a relic of the ruptured pustule)3 4
- These areas of hyperpigmentation may last for weeks or months before progressively disappearing
Key clinical features
- There is no discomfort or irritation associated with the lesions6 8
- Babies are afebrile, eating well, and otherwise healthy; there are no systemic symptoms
- Gramme stain and culture show that the lesions are sterile
- Both the differential and the white blood cell count are normal
Progression of the lesion in detail
The diagnosis is both identifiable and unique due to the evolution of TNPM lesions. A thorough chronology and progression of the lesions can be found below:
Day 1 (Birth)
These pustules manifest as white or yellowish vesicles or pustules that are superficial and non-erythematous and appear at birth.1 It is easier to distinguish this from erythema toxicum neonatorum because there is no surrounding redness.
Day 1–3
Usually, during normal handling or washing, the pustules burst on their own. The pustules go away on their own, and the fluid that is produced is clear.3
Day 3–7
- As the pustules resolve, they leave behind well-demarcated brown macules
- A collarette of fine-scale may surround the macules, resembling the peeling of the outermost skin layer
- These macules are most prominent in previously pustule-rich areas, especially on the face, trunk, and limbs5
Week 2–6
- The hyperpigmented macules gradually fade without leaving scars or permanent pigmentation
- In dark-skinned infants, the pigmentation may persist slightly longer
Months 2–3
- Complete resolution is typically seen by 8–12 weeks of life
- Skin returns to its normal tone, with no residual effects or need for treatment
Presentation in detail
TNPM presents at birth in over 95% of cases, which helps distinguish it from other neonatal dermatoses that may appear several days later1 2
Distribution of lesions
- Lesions can occur anywhere on the body.
- Common sites include:4
- Forehead and scalp
- Chin and cheeks
- Neck and back
- Buttocks and thighs
- Palms and soles (a notable feature helping in differential diagnosis)
Lesion appearance and grouping
- Lesions are often discrete, not clustered
- Unlike other pustular eruptions, TNPM lesions lack inflammation and do not coalesce.
- Infants may show lesions in all three stages simultaneously, which is pathognomonic:
- Intact pustules
- Ruptured pustules with crust
- Pigmented macules
No systemic symptoms
- Infants remain afebrile and active
- There is no irritability or feeding difficulty
- No lymphadenopathy or organomegaly
Diagnostic clues
- Gram stain of pustular content shows neutrophils only, no bacteria6,9
- The culture of fluid is sterile
- Tzanck smear is negative for multinucleated giant cells (rules out herpes)
- No eosinophils (which are seen in erythema toxicum neonatorum)
Differential diagnosis
Erythema toxicum neonatorum (ETN): Usually manifests 24 to 48 hours postpartum; eosinophil-containing erythematous lesions are seen.7
- Comedones and papules make up neonatal acne, which manifests later4
- Congenital candidiasis typically manifests as positive fungal elements and systemic symptoms
- Systemic symptoms and culture are always used to rule out bacterial infections6
- The herpes simplex virus (HSV) can cause vesicles, positive Tzanck smear results, and systemic symptoms9
Summary
A harmless, self-limiting skin ailment that primarily affects African-American neonates is called transient neonatal pustular melanosis. Pustules at birth, ruptured pustules with scale collarette, and residual hyperpigmented macules are the three stages of lesion evolution that define it.1 4
There is no need for therapy because the lesions are sterile and asymptomatic. To prevent incorrect diagnoses and needless procedures, recognition is essential. Within the first two to three months of life, full resolution is anticipated.5
FAQs
Is it possible to spread temporary newborn pustular melanosis?
TNPM is not communicable. It is a harmless, non-contagious illness.
Are there any long-term skin issues brought on by TNPM?
No. There is no permanent skin damage or scarring, and the colouring gradually disappears.
Is it possible to avoid TNPM?
Since the precise cause is unknown and unrelated to illnesses or hygiene, there are no recognised prevention strategies.
What is the diagnosis of TNPM?
Clinical diagnosis is made based on how the lesions look. To verify sterility, pustular fluid may occasionally be tested.
Are antibiotics necessary for infants with TNPM?
No. Antibiotics are not required because the lesions are sterile and free of infection.
How may bacterial pustulosis or herpes be distinguished from TNPM?
Systemic symptoms are absent from TNPM lesions, which are sterile and asymptomatic. Systemic involvement and positive pathogen tests are common in herpes and bacterial infections.
Do the spots that are left behind worry parents?
No. If therapy is not received, the pigmented areas will eventually disappear.
Do females or boys have a higher prevalence of TNPM?
The incidence of TNPM does not significantly differ by gender.
Is TNPM recurrent in later life?
No. TNPM does not recur; it is a one-time newborn disease.
Should TNPM be the date of the follow-up?
It is adequate to perform routine follow-up during routine paediatric appointments. Unless lesions become aberrant or persist abnormally long, no particular dermatological follow-up is necessary.
References
- Schachner LA, Hansen RC, Krafchik B, et al. Pediatric dermatology. 4th ed. Maryland Heights: Mosby; 2011. DermNet®
- Merlob P, Metzker A, Reisner SH. Transient neonatal pustular melanosis. Am J Dis Child. 1982;136(6):521–2. DermNet®
- Brazzelli V, Grasso V, Croci G, Figar T, Borroni G. An unusual case of transient neonatal pustular melanosis: a diagnostic puzzle. Eur J Pediatr. 2014;173(12):1655–8. DermNet®
- Boffa MM, Borg J, Grech M, Pace D, Montalto SA. Transient neonatal pustular melanosis: An unusual and challenging eruption. Clin Case Rep. 2023;11:e8092. Wiley Online Library+2Medscape+2Medscape+2
- Cleveland Clinic. Transient Neonatal Pustular Melanosis (TNPM). [Internet]. [cited 2025 Apr 7]. Available from: https://my.clevelandclinic.org/health/diseases/23111-transient-neonatal-pustular-melanosis-tnpm
- Ghosh S. Neonatal pustular dermatosis: an overview. Indian J Dermatol. 2015;60(3):211. Wikipedia
- Ferrándiz C, Coroleu W, Ribera M, Lorenzo JC, Natal A. Sterile transient neonatal pustulosis is a precocious form of erythema toxicum neonatorum. Dermatology. 1992;185(1):26–30. Wikipedia
- Patrizi A, Neri I, Gurioli C. Frequent newborn skin diseases. Clin Dermatol. 2016;34(3):271–7. Wikipedia
- Ramamurthy RS, Reveri M, Esterly NB, Fretzin DF, Pildes RS. Transient neonatal pustular melanosis. J Pediatr. 1976;88(5):831–5. Medscape+1Wikipedia+1
- DermNet. Blisters and pustules in neonates. [Internet]. [cited 2025 Apr 7]. Available from: DermNet®

